DARE bullish upcoming catalysts in 2021 and 2022
已更新
No Investment advice!
Only for practicing.
Interessting volume spikes in the past.
Upcoming Catalsyst:
DARE-BV1
Bacterial Vaginosis
1H 2021 Phase 3 trial met primary endpoint - December 7, 2020. NDA planned for 1H 2021.
*Phase 1
DARE-HRT1
Hormone replacement therapy
2021 Phase 1 initiation announced July 27, 2020. Data due 2021.
*Phase 2b
Sildenafil Cream, 3.6%
Female Sexual Arousal Disorder (FSAD)
2021 Phase 1 initiation announced July 27, 2020. Data due 2021.
*
Phase 3
Ovaprene
Contraception
2022 Pivotal trial data due in 2022.
Only for practicing.
Interessting volume spikes in the past.
Upcoming Catalsyst:
DARE-BV1
Bacterial Vaginosis
1H 2021 Phase 3 trial met primary endpoint - December 7, 2020. NDA planned for 1H 2021.
*Phase 1
DARE-HRT1
Hormone replacement therapy
2021 Phase 1 initiation announced July 27, 2020. Data due 2021.
*Phase 2b
Sildenafil Cream, 3.6%
Female Sexual Arousal Disorder (FSAD)
2021 Phase 1 initiation announced July 27, 2020. Data due 2021.
*
Phase 3
Ovaprene
Contraception
2022 Pivotal trial data due in 2022.
注释
交易结束：到达目标
nice spike! Hit my Target
Join Discord channel:
whop.com/marketplace/contingent-traders/
contingenttrader.com/
whop.com/marketplace/contingent-traders/
contingenttrader.com/
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。